Jefferies Group LLC Editas Medicine, Inc. Call Options Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Sep 21, 2023
BUY
$9.99 - $21.35 $65,934 - $140,910
6,600 Added 13.64%
55,000 $650,000
Q2 2022

Aug 15, 2022
BUY
$9.99 - $21.35 $65,934 - $140,910
6,600 Added 13.64%
55,000 $651,000
Q1 2022

Sep 21, 2023
SELL
$14.08 - $27.63 $92,928 - $182,358
-6,600 Reduced 12.0%
48,400 $920,000
Q1 2022

May 16, 2022
BUY
$14.08 - $27.63 $681,472 - $1.34 Million
48,400 New
48,400 $921,000

Others Institutions Holding EDIT

# of Institutions
252
Shares Held
58.7M
Call Options Held
494K
Put Options Held
417K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $234M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email